Stamatia Karagianni

Stamatia Karagianni is a PhD candidate at the University of Gothenburg (Sweden) specialising in neurodegenerative disease biomarkers, with a BSc in Psychology from the National and Kapodistrian University of Athens and a Research MSc in Cognitive Neuropsychology from Vrije Universiteit Amsterdam. Her research journey began with blood-based biomarkers of Alzheimer’s disease (AD) at the Alzheimer Center Amsterdam, where she developed a particular interest in their diagnostic performance and clinical translation. She subsequently expanded her expertise into neuroimaging to investigate the spatial distribution of pathological tau and its relationship with disease progression. Her doctoral research integrates blood-based biomarkers and advanced neuroimaging to investigate the detection, measurement, and progression of neurodegenerative pathology. Her work includes the validation of regulatory-approved plasma biomarkers, particularly p-tau217, against established reference standards, includi